BioWorld MedTech

July 9, 2018

Implandata eyes European launch of intraocular pressure sensor

LONDON – Implandata Ophthalmic Products GmbH is gearing up for the European launch of its Eyemate implantable intraocular pressure sensor, as it nears the second closing of a €8 million (US$9.3 million) series C round. Read More

Quantum raises $50M in series A to develop robotic liver cancer treatment

ICD implant rates study says docs eased up after DoJ action

Mount Sinai researchers discover microRNA activity biomarkers in bladder cancer

Toronto lab develops system to eliminate HCV in donated lungs

Financings

Regulatory front

Product briefs

BioWorld MedTech stock report for public med-tech companies

BioWorld MedTech's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for Jan 23, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 23, 2026.

Illustration of human body surrounded by DNA, cell and drug icons

Cell/gene therapy sector now sustainable; China competition mounting

BioWorld

There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...

Illustration of magnifying glass inspecting brain

Neurotrimin unveiled as marker in intellectual disability

BioWorld Science

Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...

DNA mutations or genetic disorder concept art

Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease

BioWorld Science

Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...